RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
<p>Angiotensin converting enzyme inhibitors are the first line medicine for the treatment of the most of cardiovascular diseases. There is no class-effect for these drugs in myocardial infarction therapy. Moreover in myocardial infarction angiotensin converting enzyme inhibitors have significa...
Saved in:
Main Authors: | I. V. Szirov (Author), E. V. Malichenko (Author) |
---|---|
Format: | Book |
Published: |
Столичная издательская компания,
2015-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
by: I. V. Szirov, et al.
Published: (2015) -
COMPARATIVE EFFICACY OF ACE INHIBITORS (RAMIPRIL VS ENALAPRIL) IN TREATMENT OF CHRONIC HEART FAILURE IN WOMEN
by: S. N. Tereshchenko, et al.
Published: (2016) -
THROMBOLYTIC THERAPY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
by: E. V. Konstantinova, et al.
Published: (2016) -
RAMIPRIL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION AND ISCHEMIC HEART DISEASE
by: A. I. Chesnikova, et al.
Published: (2016) -
Regulation of extracellular matrix In patients with Q-wave myocardial infarction after thrombolytic therapy
by: V. D. Syvolap, et al.
Published: (2014)